Your browser doesn't support javascript.
loading
The bitter side of epigenetics: variability and resistance to chemotherapy.
Hajji, Nabil; García-Domínguez, Daniel J; Hontecillas-Prieto, Lourdes; O'Neill, Kevin; de Álava, Enrique; Syed, Nelofer.
Afiliação
  • Hajji N; The John Fulcher Molecular Neuro-Oncology Laboratory, Division of Brain Sciences, Imperial College London, London, UK.
  • García-Domínguez DJ; Institute of Biomedicine of Seville (IbiS), Virgen del Rocío University Hospital/CSIC/University of Seville/CIBERONC, Spain.
  • Hontecillas-Prieto L; Institute of Biomedicine of Seville (IbiS), Virgen del Rocío University Hospital/CSIC/University of Seville/CIBERONC, Spain.
  • O'Neill K; The John Fulcher Molecular Neuro-Oncology Laboratory, Division of Brain Sciences, Imperial College London, London, UK.
  • de Álava E; Institute of Biomedicine of Seville (IbiS), Virgen del Rocío University Hospital/CSIC/University of Seville/CIBERONC, Spain.
  • Syed N; The John Fulcher Molecular Neuro-Oncology Laboratory, Division of Brain Sciences, Imperial College London, London, UK.
Epigenomics ; 13(5): 397-403, 2021 03.
Article em En | MEDLINE | ID: mdl-29932342
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Resistencia a Medicamentos Antineoplásicos / Epigênese Genética / Neoplasias / Antineoplásicos Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Resistencia a Medicamentos Antineoplásicos / Epigênese Genética / Neoplasias / Antineoplásicos Idioma: En Ano de publicação: 2021 Tipo de documento: Article